Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Selten Pharma, Inc Company Data Life Care Centers of America Life Care Centers of America, Inc. (LCCA) is a privately owned managed healthcare organization. The company operates nursing homes, assisted living facilities, and retirement centers across the US. It offers a range of living arrangements and amenities, services and care to its residents. LCCA’s portfolio of services includes Life Care physician services and Alzheimer's care, rehabilitation, assisted living, home care, nursing care and retirement centers. The company manages 220 nursing homes, assisted living, retirement, home care and Alzheimer’s centers across 28 states in the US. It along with its subsidiary, namely, Life Care Physician Services, LLC, operates in the US. LCCA is headquartered in Cleveland, the US. Company Data Langer, Inc. Langer, Inc. (Langer) is a US based company primarily involved in the design, manufacture and distribution of medical products and services targeting the long-term care, orthopedic, orthotic and prosthetic markets. Its subsidiaries include Twincraft, Inc.; Regal Medical Inc. and Silipos, Inc. Through these subsidiaries, the company has ventured into personal care products market and patient services market such as long-term care settings which involves facility personnel in product selection, order fulfillment, product fitting and billing services. In addition, the company principally operates in the US and Canada with operations in more than 30 other countries worldwide. The company is head quartered in New York, US. Company Data Pharmaceutical Product Development, Inc. Pharmaceutical Product Development, Inc (PPD) is a global leading contract research organization that provides drug discovery, development and lifecycle management services to its customers. Its drug development services comprise preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, and bioanalytical good manufacturing practices (cGMP), global central laboratory and vaccines and biologics laboratory services. The company provides clinical trial expertise across a wide range of therapeutic areas to over 100 countries, spanning across six continents. In addition, PPD offers support for marketed drugs, biologics and devices, with medical information, patient compliance programs, product safety and pharmacovigilance, patient and disease registry programs, observational studies, standard response document development, Phase IV monitored studies and prescription to over-the-counter programs. The company operates under two business segments, Clinical Development Services and Laboratory Services. It owns and operates 86 offices across 43 countries worldwide. The company’s partners and clients include biotechnology, pharmaceutical, medical device, academic, government and non-profit organizations. PPD is headquartered in Wilmington, North Carolina, the US. Company Data Blue Cross Blue Shield of Michigan Blue Cross Blue Shield of Michigan (BCBSM) is an independent non-profit organization providing and administering health benefits to the residents of Michigan, and the members of Michigan-headquartered groups residing outside the state. The organization delivers health insurance services in the Michigan state under license from the Blue Cross Blue Shield association. BCBSM offers health care coverage, including individual coverage, group coverage, Medicare plans, managed plans, health management plans, medical and dental care programs. The company also offers prescription drug coverage, preventive care and office visits plans, medical plan with a health savings account, and healthy communities grant programs. The company along with its subsidiaries primarily operates in the Michigan state of the US. BCBSM is headquartered in Michigan, the US. The company seeks to enhance its patient-centered medical home program through strategic collaborations with doctors and hospitals. Company Data Lombard Medical Technologies PLC Lombard Medical Technologies PLC (LMT) is a medical technology company. The company develops, manufactures and supplies endovascular stent grafts, which is used in the repair of aortic aneurysms. It also develops device solutions for the abdominal aortic aneurysm repair market. LMT’s Aorfix is an endovascular stent graft for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees. The company’s Aorfix is used to treat aortic, aortoiliac and iliac aneurysms. It sells its products in Europe and parts of South America through a network of local distributors. LMT is headquartered in Didcot, Oxfordshire, the UK. Company Data Hologic, Inc. Hologic, Inc. (Hologic) is one of the leading providers of diagnostic products, medical imaging systems and surgical products. Its major products include diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company sells and services its products through a net work of direct sales and service forces and through independent distributors and sales representatives. The company operates in Americas, Europe and Asia-Pacific. Hologic is headquartered in Bedford, the US. Hologic envisages establishing its position growing continuously and expanding its global presence; tapping into new business areas; enhancing product-mix; fostering operational excellence and flexibility; pursuing long term strategic partnerships and agreements; and strategic acquisitions of small and medium-sized enterprises that supplement the company’s existing portfolio . Company Data Bristol-Myers Squibb Company Bristol-Myers Squibb Company (BMS) is global biopharmaceutical company focused at addressing the unmet medical needs of patients with serious diseases. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biopharmaceuticals and related healthcare products. The company focuses on the areas including cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/AIDS and rheumatoid arthritis. Its product line includes chemically-synthesized drugs and biological products. BMS has research and development facilities in the US, Belgium, England, France and Japan; and it also has manufacturing facilities in Puerto Rico, the US, France, Italy, Ireland, Japan, Mexico and China. BMS is headquartered in New York, the US. BMS envisages establishing its position through the development of innovative drugs and enhancement of existing ones, internal development, strong partner relationships, strategic collaborations and acquisitions. As a part of its acquisition strategy the company recently acquired Flexus Biosciences to expand its immune-oncology product line. Company Data F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain diseases, viral and bacterial infections, debilitating diseases, cardiovascular and metabolism diseases; point-of-care testing devices; analyzers; blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. Roche offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. The company has operations in more than 150 countries in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Roche is headquartered in Basel, Switzerland. Roche seeks to maintain its position in the market through new product launches, network expansion, internal development, in-licensing of technology and products, acquisitions and strategic alliances. Company Data Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited (Teva) is a fully integrated global pharmaceutical company. It undertakes the development, manufacture and marketing of a wide range of generic and branded pharmaceuticals and active pharmaceutical ingredients (APIs). The company offers chemical and therapeutic equivalents of originator pharmaceuticals in a wide range of dosage forms, including capsules, tablets, ointments, liquids, creams, injectables and inhalants. Teva also provides an array of over the counter (OTC) products through a joint venture with P&G. The company is also a specialty pharmaceuticals innovator focusing on various disease areas including multiple sclerosis, Parkinson's disease, autoimmune diseases, cancer, women's health and respiratory products. Teva operates in more than 60 countries and distributes its products across the world. Teva is headquartered in Tikva, Israel. Teva seeks to maintain and expand its leadership position in the global generics market. The company adopts organic and inorganic growth strategies to achieve its goal. Company Data Varian Medical Systems, Inc. Varian Medical Systems, Inc. (Varian) is a provider of medical devices and software for the treatment of cancer. It designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. The company offers X-ray tubes and digital image detectors that are used in medical, dental, veterinary, scientific and industrial sectors. It designs, manufactures, sells and services linear accelerators, image processing software and image detection products for security and inspection purposes and proton therapy products and systems for cancer treatment. The company, together with its subsidiaries and manufacturing facilities, operates in North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US. Varian secured the US FDA approval for several products including Truebeam Stx-Edge radiotherapy delivery system; Varian Head Frame; Varian Verification system; Universal Segmented Cylinder Applicator; and Smart Segmentation Knowledge Based Contouring system, among others. These approvals enable the company to expand its operations in the US. Company Data Zimmer Holdings, Inc. Zimmer Holdings, Inc. (Zimmer) is a medical device company. It carries out the design, development, manufacture, and marketing of reconstructive orthopaedic implants, dental implants, spinal and trauma products and related orthopaedic surgical products. Its major product line comprises orthopaedic reconstructive product line that includes knee implants, hips implants and extremities; dental implants; trauma products; spine implants; and orthopaedic surgical products. Zimmer has direct presence in around 25 countries the world over and sells its products in over 100 countries. Its major markets are concentrated in Americas, Europe and Asia Pacific. Zimmer is headquartered in Indiana, the US. Zimmer seeks to elongate its leadership position in musculoskeletal health market through focusing on joint reconstructive category and other musculoskeletal categories like, extremities and emerging businesses. Besides, it carries out massive geographical expansion initiatives to tap high value multinational clients. Company Data AtriCure, Inc. AtriCure, Inc. (AtriCure) is a medical device company. It carries out the development, manufacture and sales of innovative cardiac surgical ablation devices. The company's ablation devices are designed to create precise lesions or scars in cardiac and soft tissues. The major products of the company include Isolator’s Synergy ablation system, a bipolar ablation clamp system and related radiofrequency ablation devices; Estech’s radio frequency ablation devices; cryoICE cryoablation system and AtriClip left atrial appendage (LAA) occlusion system. It also offers Lumitip dissectors and Estech’s line of reusable cardiac surgery instruments. The company markets and sells its products in selected markets outside of the US through independent distributors and through its European subsidiary in EMEA markets. AtriCure is headquartered in Ohio, the US. The company focuses on the expansion of its product portfolio by building a strong operating base, besides gaining expertise through acquisitions and collaborations. AtriCure seeks to obtain expanded US FDA clearances and approvals in order to achieve market acceptance for its products. Company Data Nektar Therapeutics Nektar Therapeutics (Nektar) is a biopharmaceutical company. It carries out discovery and development of a pipeline of novel therapeutic drug candidates based on its PEGylation and advanced polymer conjugate technology platforms to address unmet medical needs. The company’s products focuses on various therapeutic areas, including, cancer, pain, anti-infectives, anti-viral and immunology among others. The company’s technology has enabled several approved products in the US and Europe through partnerships with leading biopharmaceutical companies, including Roche's PEGASYS for hepatitis C, Amgen's Neulasta for neutropenia and UCB's Cimzia for Crohn's disease and rheumatoid arthritis. Its research and development activities involve peptides, small molecule drugs, and other potential biologic drug candidates. Nektar Therapeutics is headquartered in San Francisco, California, the US. Company Data Isis Pharmaceuticals, Inc. Isis Pharmaceuticals, Inc. (Isis) is a leading company in RNA-targeted drug discovery and development. It specializes in anti-sense technology. The company carries out the discovery and development of new class antisense drugs that address significant unmet medical needs. Antisense technology is a direct route from genomics to drugs. KYNAMRO (mipomersen sodium) injection is the lead product candidate of the company which has been developed in collaboration with Genzyme. It is used for the reduction of low-density lipoprotein cholesterol in patients suffering from homozygous familial hypercholesterolemia, or HoFH. The product pipeline of the company focuses on various therapeutic areas, namely, cardiovascular, cancer, metabolic, neurodegenerative, inflammatory and other diseases. Isis is headquartered in Carlsbad, California, the US. Company Data Eli Lilly and Company Eli Lilly and Company (Lilly) is a US based innovation driven pharmaceutical company. It carries out the discovery, development, manufacture and marketing of products. The company’s product portfolio consists of neuroscience products, endocrinology products, oncology products, cardiovascular products, animal health products and other pharmaceutical products. The company’s research efforts are mainly focused on five therapeutic domains, namely, cancer; endocrine diseases such as diabetes, obesity, and musculoskeletal disorders; central nervous system; autoimmune diseases; and cardiovascular diseases. The company’s products are sold in several countries across the world. Lilly is headquartered in Indiana, the US. The company focuses on creating value for all its stakeholders by enhancing the flow of innovative new medicines in human health and animal health providing improved outcomes for individual patients across the world. To this end, the company in March 2015 entered into a major collaboration agreement with Innovent Biologics, Inc. to support the development and potential commercialization of at least three cancer treatments over the next decade. Company Data Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated (Vertex) is a biotechnology company. It carries out the discovery, development and commercialization of small molecule drugs for the treatment of serious and life-threatening ailments. The company offers Incivek (telaprevir) for the treatment of patients with genotype 1 hepatitis C virus (HCV) infection, and Kalydeco (ivacaftor) for the treatment of patients with cystic fibrosis (CF). The company’s research and development efforts focus on influenza and bacterial infections, inflammatory diseases, cancer, neurological diseases and disorders including pain, and cystic fibrosis. It has operations in the US, the UK, and Canada. Vertex is headquartered in Boston, Massachusetts, the US. The company’s strategic business objectives include global Launch of Kalydeco in cystic fibrosis and expansion of its Kalydeco development program. Company Data Merck & Co., Inc. Merck & Co., Inc. (Merck), also known as MSD outside the US and Canada, is a research-driven global healthcare company. It conducts the discovery, development, manufacture and commercialization of branded pharmaceuticals, biologic therapies, prescription and over-the-counter (OTC) pharmaceuticals, vaccines, consumer care products and animal healthcare products. The major clients of the company include wholesalers and retailers, hospitals, government agencies, managed health care providers, and veterinarians. Merck sells its products through direct sales force and a network of subsidiaries and joint ventures across the US, Europe, the Middle East and Africa, Asia Pacific and Other countries. Merck is headquartered in Whitehouse Station, New Jersey, the US. Company Data Stryker Corporation Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; and medical devices used in a variety of medical specialties. Stryker sells its products in the US, Europe, Japan, Asia Pacific, Canada and Latin America. It sells its products through its subsidiaries and branches, besides third-party dealers and distributors. Stryker is headquartered in Michigan, the US. The company's strategy is to gain a strong foothold in the healthcare arena and expand its operations in a highly innovative, high-growth space, which would enable it to become a market leader in the neurovascular area. In line with this strategy, the company acquired CHG Hospital Beds, Inc., Small Bone Innovations, Inc., Berchtold Holding, AG, and Patient Safety Technologies, Inc. among others Company Data Royal DSM N.V. Royal DSM N.V. (DSM) is a global life sciences and materials sciences company. It primarily focuses health, nutrition and materials sectors. The company offers a wide range of products, ranging from anti-invectives, polyesters, vitamins, to oil and gas across diverse end markets. It offers its products and services to animal and human health and nutrition, personal care, pharmaceuticals, automotive, medical materials, food and beverages, packaging, electrical and electronics, coatings and paint, alternative energy, housing, and life protection markets. DSM is headquartered at Heerlen, Netherlands. The company’s strategy has been to expand its activities across major regions through acquisitions and joint ventures. In line to its business, the company acquired 19% interest in Yantai Andre Pectin Co. Ltd., a China-based producer of texturing ingredients. Company Data
1-20 of 1534 results

See all companies